Chemical Name: 4-[4-(tert-Butylamino)piperidin-1-yl]-N-[(4-chlorophenyl)methyl]quinoline-2-amine hydrochloride. Alternate Names: Ezurpimtrostat HCl
PPT1 inhibitor/STING activator
Molekulargewicht:
459.46
Reinheit:
>98% by HPLC NMR (Conforms)
Formulierung:
White to off-white solid
CAS Nummer:
[1914148-73-4]
Formel:
C25H31ClN4HCl
Anwendungsbeschreibung:
GNS561 induces lysosomal dysregulation leading to inhibition of autophagy.1 It displayed efficacy against intrahepatic cholangiocarcinoma1 and hepatocellular carcinoma2. GNS561 acted as an anti-fibrotic agent against liver fibrosis in a rat model.3 GNS561-induced cell death is partially caused by inhibition of palmitoyl-protein thioesterase 1 (PPT1) leading to lysosomal dysfunction.4 GNS561 treatment of prostate and ovarian cancer models enhanced STING expression and activation via PPT1 inhibition leading to infiltration of cytotoxic T cells.5 GNS561 represents a potentially novel immunotherapy for cold tumors.
10-4138
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten